Cellphire
is a Maryland-based biotechnology company that develops and commercializes stabilized cellular materials to treat bleeding and blood-related ailments... Read moreCellphire
is a Maryland-based biotechnology company that develops and commercializes stabilized cellular materials to treat bleeding and blood-related ailments... Read more
2005
PrivateIndependent Company
News
Mar 17, 2025
GlobalNewswire
Press Release: Cellphire : Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
Dec 05, 2023
Cellphire Youtube Channel
Cellphire posted a video "FPH" on YOUTUBE
Mar 29, 2022
PR Newswire
Press Release: Cellphire : Cellphire Therapeutics Treats First Patient in Phase 2/3 Cryopreserved Platelets Clinical Trial
May 27, 2021
Markets Insider
Cellphire: Cellphire Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Thrombosomes in Bleeding Thrombocytopenic Patients
Apr 20, 2021
MarketScreener
Cellphire: Cellphire Therapeutics Names Michael Gaffney as Company's New CEO
Apr 05, 2021
Drug Delivery Business
Cellphire: Cellphire Therapeutics closes $15M Series A
Apr 02, 2021
PR Newswire
Press Release: Cellphire : Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led by Simcah Management
Sep 23, 2020
Baltimore Citybizlist
Cellphire: Cellphire President G. Michael Fitzpatrick Awarded Armed Services Program Lifetime Achievement Award
May 14, 2020
PR Newswire
Press Release: Cellphire : Cellphire Announces Orphan Drug Designation of Thrombosomes for Treatment of Acute Radiation Syndrome
Apr 21, 2020
Benzinga
Cellphire: Cellphire Announces Exercise by BARDA of Option 3 of Contract to Develop Platelet-Based Hemostatic
Cellphire Competitors
1
2
3
4
5
6
7
8